In this podcast we discuss the regulatory environment for clinical trials, including international comparisons, current opportunities, the role of the MHRA and the Government, and the importance o the NHS. We are joined by Dr Giles Campion, Managing Director of Silence Therapeutics, and Professor Sir Gordon Duff, Chairman of the Science Advisory Board of Silence Therapeutics.